For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221125:nRSY6672Ha&default-theme=true
RNS Number : 6672H NatWest Group plc 25 November 2022
25 November 2022
NatWest Group plc
INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY ("PDMRs") IN ACCORDANCE WITH ARTICLE 19 OF THE MARKET ABUSE
REGULATION
1. NatWest Group plc (the "Company") announces that options to acquire
ordinary shares of £1.0769* each in the Company ("Shares")
(ISIN:GB00BM8PJY71) were granted to PDMRs on 25 November 2022 under the
NatWest Group plc 2017 UK ShareSave Plan ("Plan"), at the option price of
£1.8619 per Share, as set out below.
Name of PDMR Position of PDMR No. of options granted
1,933
Scott Marcar Chief Information Officer
1,933
Andrew McLaughlin CEO, Commercial & Institutional for the non-ring-fenced bank
Subject to the rules of the Plan, the options will become exercisable from 18
December 2025. This transaction took place outside of a trading venue.
2. The Company also announces that it has been notified of the PDMRs set
out below selling Shares on the date and at the price indicated:
Name of PDMR Position of PDMR No. of Shares sold Price of Shares sold Date Shares sold
Robert Begbie CEO, NatWest Markets 200,000 £2.5445 23 November 2022
Andrew McLaughlin CEO, Commercial & Institutional for the non-ring-fenced bank 164,495 £2.5878 24 November 2022
The above transactions took place on the London Stock Exchange (XLON).
* Note: the nominal value of ordinary shares without rounding is
£1.076923076923077 per share
Legal Entity Identifier: 2138005O9XJIJN4JPN90
For further information contact:-
NatWest Group Investor Relations
Alexander Holcroft
Head of Investor Relations
+44(0)20 7672 1758
NatWest Group Media Relations
+44(0)131 523 4205
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFEEFEIEESEIF